Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis.

Dawn Wendy LangdonDavorka TomicIris-Katharina PennerPasquale CalabreseGary CutterDieter A HäringFrank DahlkeLudwig Kappos

Published in: European journal of neurology (2021)

Early fingolimod treatment may offer long-term cognitive benefit in patients with relapsing-remitting MS.

Keyphrases